Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Jan 6, 2023
- Accession no.
- 0001209191-23-002460
- Filed
- Jan 6, 2023
- Trade date
- Apr 25, 2022-Jan 5, 2023
- Filing delay
- 256 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 18 non-derivative transactions and 4 derivative transactions. Open-market sales total $155.2K. It was filed 256 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001209191-23-026045 (Apr 28, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 | Class A Common Stock | GGiftDisposed | −12,000 | $0.00 | $0 | 570,805 | Direct | |
| May 12, 2022 | Class A Common Stock | GGiftDisposed | −12,000 | $0.00 | $0 | 558,805 | Direct | |
| May 19, 2022 | Class A Common Stock | GGiftDisposed | −12,000 | $0.00 | $0 | 546,805 | Direct | |
| Jun 21, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 543,805 | Direct | |
| Jul 19, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 540,805 | Direct | |
| Aug 17, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 537,805 | Direct | |
| Sep 19, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 534,805 | Direct | |
| Oct 19, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 531,805 | Direct | |
| Nov 16, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 528,805 | Direct | |
| Dec 14, 2022 | Class A Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 525,805 | Direct | |
| Jan 5, 2023 | Class A Common Stock | CConversionAcquired | +18,500 | $0.00 | $0 | 544,305 | Direct | |
| Jan 5, 2023 | Class A Common Stock | SSaleDisposed | −18,500 | $7.39F3 | −$136,715 | 525,805 | Direct | |
| Jan 5, 2023 | Class A Common Stock | CConversionAcquired | +500 | $0.00 | $0 | 500 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | SSaleDisposed | −500 | $7.38F5 | −$3,690 | 0 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | CConversionAcquired | +1,000 | $0.00 | $0 | 1,000 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | SSaleDisposed | −1,000 | $7.39F7 | −$7,390 | 0 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | CConversionAcquired | +1,000 | $0.00 | $0 | 1,000 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | SSaleDisposed | −1,000 | $7.38F9 | −$7,380 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Class A Common Stock | CConversionDisposed | −18,500 | $0.00 | $0 | 6,658,834 | Direct | |
| Jan 5, 2023 | Class A Common Stock | CConversionDisposed | −500 | $0.00 | $0 | 540,000 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | CConversionDisposed | −1,000 | $0.00 | $0 | 530,000 | Indirect | |
| Jan 5, 2023 | Class A Common Stock | CConversionDisposed | −1,000 | $0.00 | $0 | 126,875 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $7.29 to $7.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $7.30 to $7.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $7.33 to $7.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $7.30 to $7.67 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.